While Foundayo is well-tolerated by most people, some should not take the drug, including: Those with a history or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or other thyroid cancers should not take Foundayo
Senses 37 , 769797 (2012)
Studies have demonstrated that GLP-1RAs confer therapeutic benefits in various T2D- or obesity-related conditions, including polycystic ovary syndrome (80), metabolic syndrome (81), non-alcoholic fatty liver disease (82) and obesity- or diabetes-associated malignancies, such as gallbladder, ovarian and esophageal cancers (73,79)
There is no medical intake, provider review, or diagnostic testing involved at any stage of the ordering or usage process
Nat Mater 8(4):331336 Li H, Liu R, Lian S, Liu Y, Huang H, Kang Z (2013) Near-infrared light controlled photocatalytic activity of carbon quantum dots for highly selective oxidation reaction
A randomised controlled trial was conducted in 2022 investigating the impact of semaglutide and liraglutide on weight loss in individuals living with obesity